Kawasaki disease: etiopathogenesis and novel treatment strategies

Shreya Agarwal, Devendra K. Agrawal

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Introduction: Kawasaki disease is an acute febrile systemic vasculitis that predominantly occurs in children below five years of age. Its etiopathogenesis is still not clear, but it is thought to be a complex interplay of genetic factors, infections and immunity. Areas covered: This review article discusses in detail Kawasaki disease, with particular emphasis on the recent updates on its pathogenesis and upcoming alternate treatment options. Though self-limiting in many cases, it can lead to severe complications like coronary artery aneurysms and thrombo-embolic occlusions, and hence requires early diagnosis and urgent attention to avoid them. Intravenous immunoglobulin (IVIG) with or without aspirin has remained the sole treatment option for these cases, but 10–15% cases develop resistance to this treatment. Expert commentary: There is a need to develop additional treatment strategies for children with Kawasaki disease. Targeting different steps of pathogenesis could provide us with alternate therapeutic options.

Original languageEnglish (US)
Pages (from-to)247-258
Number of pages12
JournalExpert Review of Clinical Immunology
Volume13
Issue number3
DOIs
StatePublished - Mar 4 2017

Fingerprint

Mucocutaneous Lymph Node Syndrome
Coronary Aneurysm
Therapeutics
Systemic Vasculitis
Intravenous Immunoglobulins
Aspirin
Early Diagnosis
Immunity
Coronary Vessels
Fever
Infection

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Kawasaki disease : etiopathogenesis and novel treatment strategies. / Agarwal, Shreya; Agrawal, Devendra K.

In: Expert Review of Clinical Immunology, Vol. 13, No. 3, 04.03.2017, p. 247-258.

Research output: Contribution to journalReview article

@article{5853f3474fa84a6583f5cf65bc47bfa7,
title = "Kawasaki disease: etiopathogenesis and novel treatment strategies",
abstract = "Introduction: Kawasaki disease is an acute febrile systemic vasculitis that predominantly occurs in children below five years of age. Its etiopathogenesis is still not clear, but it is thought to be a complex interplay of genetic factors, infections and immunity. Areas covered: This review article discusses in detail Kawasaki disease, with particular emphasis on the recent updates on its pathogenesis and upcoming alternate treatment options. Though self-limiting in many cases, it can lead to severe complications like coronary artery aneurysms and thrombo-embolic occlusions, and hence requires early diagnosis and urgent attention to avoid them. Intravenous immunoglobulin (IVIG) with or without aspirin has remained the sole treatment option for these cases, but 10–15{\%} cases develop resistance to this treatment. Expert commentary: There is a need to develop additional treatment strategies for children with Kawasaki disease. Targeting different steps of pathogenesis could provide us with alternate therapeutic options.",
author = "Shreya Agarwal and Agrawal, {Devendra K.}",
year = "2017",
month = "3",
day = "4",
doi = "10.1080/1744666X.2017.1232165",
language = "English (US)",
volume = "13",
pages = "247--258",
journal = "Expert Review of Clinical Immunology",
issn = "1744-666X",
publisher = "Expert Reviews Ltd.",
number = "3",

}

TY - JOUR

T1 - Kawasaki disease

T2 - etiopathogenesis and novel treatment strategies

AU - Agarwal, Shreya

AU - Agrawal, Devendra K.

PY - 2017/3/4

Y1 - 2017/3/4

N2 - Introduction: Kawasaki disease is an acute febrile systemic vasculitis that predominantly occurs in children below five years of age. Its etiopathogenesis is still not clear, but it is thought to be a complex interplay of genetic factors, infections and immunity. Areas covered: This review article discusses in detail Kawasaki disease, with particular emphasis on the recent updates on its pathogenesis and upcoming alternate treatment options. Though self-limiting in many cases, it can lead to severe complications like coronary artery aneurysms and thrombo-embolic occlusions, and hence requires early diagnosis and urgent attention to avoid them. Intravenous immunoglobulin (IVIG) with or without aspirin has remained the sole treatment option for these cases, but 10–15% cases develop resistance to this treatment. Expert commentary: There is a need to develop additional treatment strategies for children with Kawasaki disease. Targeting different steps of pathogenesis could provide us with alternate therapeutic options.

AB - Introduction: Kawasaki disease is an acute febrile systemic vasculitis that predominantly occurs in children below five years of age. Its etiopathogenesis is still not clear, but it is thought to be a complex interplay of genetic factors, infections and immunity. Areas covered: This review article discusses in detail Kawasaki disease, with particular emphasis on the recent updates on its pathogenesis and upcoming alternate treatment options. Though self-limiting in many cases, it can lead to severe complications like coronary artery aneurysms and thrombo-embolic occlusions, and hence requires early diagnosis and urgent attention to avoid them. Intravenous immunoglobulin (IVIG) with or without aspirin has remained the sole treatment option for these cases, but 10–15% cases develop resistance to this treatment. Expert commentary: There is a need to develop additional treatment strategies for children with Kawasaki disease. Targeting different steps of pathogenesis could provide us with alternate therapeutic options.

UR - http://www.scopus.com/inward/record.url?scp=85013025243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013025243&partnerID=8YFLogxK

U2 - 10.1080/1744666X.2017.1232165

DO - 10.1080/1744666X.2017.1232165

M3 - Review article

C2 - 27590181

AN - SCOPUS:85013025243

VL - 13

SP - 247

EP - 258

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

SN - 1744-666X

IS - 3

ER -